What are probiotics?
Probiotics are the friendliest types of bacteria which are found in the normal ‘microflora’. Find out more about microflora here.Read more…
Scientific and clinical studies have been continuously conducted on the Lab4 probiotic for over 15 years. In this section, you will find a summary of the major clinical trials.Read more…
What is Lab4?
The Lab4 consortium of probiotic bacteria has been incorporated into many popular brands of probiotic and has benefited thousands of people for over 15 years.Read more…
Buy the products
View the different ways in which Lab4 Probiotics are used and buy products here.Buy products…
Q. What is Lab4?
Lab4 is the name given to the probiotic bacteria strains, developed by Cultech Ltd, the Welsh based nutraceutical company. There is a Lab4 for adults and Lab4 for pregnancy, and infants from birth to four years, and both types have substantial independent evidence supported their health benefits. The Lab4b contains Lactobacillus salivarius; Lactobacillus paracasei, Bifidobacterium animalis subs. lactis and Bifidobacterium bifidum.
Q. What are probiotics?
Probiotics are live microbial food ingredients that have a beneficial effect on health when taken in the right amounts. It’s not clear yet exactly how probiotics have these effects, but research shows that they play an important role in improving digestion and intestinal health as well as the helping to regulate and stimulate the immune system.
Q. Can probiotics help combat allergies?
New, breakthrough clinical evidence about to be published in the Journal of Allergy and Clinical Immunology and being presented at the Royal College of Paediatrics and Child Health (RCPCH) annual conference in Glasgow (22-24 May 2012), demonstrates that probiotics can significantly reduce the risk of allergy in children. Lab4 probiotics were taken by mothers during the latter part of pregnancy and given daily to their babies in the first six months following birth. The probiotic halved the risk of allergic sensitisation in infants up to two years of age. Remarkably, the risk of atopic eczema was also reduced by over 50% and this is likely to significantly reduce asthma and rhinitis into older childhood and as adults.